Plus Therapeutics Presents Preliminary Safety and Feasibility Data from ReSPECT-LM Clinical Trial at the European Association of Nuclear Medicine Congress
Plus Therapeutics Presents Preliminary Safety and Feasibility Data from ReSPECT-LM Clinical Trial at the European Association of Nuclear Medicine Congress – Nanotechnology News Today – EIN Presswire
Trusted News Since 1995
A service for nanotechnology industry professionals
·
Wednesday, October 19, 2022
·
596,741,246
Articles
·
3+ Million Readers
